3,5-二甲基吡唑-4-硼酸频那醇酯 、 Dicaesio carbonate 、 (2-溴乙氧基)-特丁基二甲基硅烷 在
silica gel 、 乙酸乙酯 作用下,
以
乙腈 为溶剂,
以to give the title compound (300 mg, 77%) as a yellow oil的产率得到1-(2-((tert-butyldimethylsilyl)oxy)ethyl)-3,5-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder:
wherein R
1
, R
2
, R
3
, R
4
, R
5
, and n are as defined herein.